Arrowstreet Capital
ZYME icon

Arrowstreet Capital’s Zymeworks ZYME Stock Holding History

Arrowstreet Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Sell
418,497
-325,401
-44% -$8.27M ﹤0.01% 1047
2026
Q1 		$18.6M Buy
743,898
+43,896
+6% +$1.04M 0.01% 765
2025
Q4 		$18.4M Buy
700,002
+386,249
+123% +$8.42M 0.01% 759
2025
Q3 		$5.36M Buy
+313,753
New +$4.49M ﹤0.01% 1151
2024
Q4 		– Sell
-407,771
Closed -$5.12M – 2015
2024
Q3 		$5.12M Buy
+407,771
New +$4.44M ﹤0.01% 957
2024
Q2 		– Sell
-581,558
Closed -$6.12M – 1817
2024
Q1 		$6.12M Buy
581,558
+214,540
+58% +$2.38M 0.01% 831
2023
Q4 		$3.81M Sell
367,018
-104,987
-22% -$837K ﹤0.01% 828
2023
Q3 		$2.99M Sell
472,005
-70,225
-13% -$519K ﹤0.01% 766
2023
Q2 		$4.68M Buy
+542,230
New +$4.85M 0.01% 640
2021
Q2 		– Sell
-90,111
Closed -$2.85M – 2274
2021
Q1 		$2.85M Buy
90,111
+19,598
+28% +$796K ﹤0.01% 1425
2020
Q4 		$3.33M Buy
+70,513
New +$3.27M ﹤0.01% 1393
2020
Q1 		– Sell
-12,264
Closed -$558K – 2158
2019
Q4 		$558K Buy
+12,264
New +$446K ﹤0.01% 1474
2019
Q2 		– Sell
-138,896
Closed -$2.25M – 1753
2019
Q1 		$2.25M Buy
138,896
+102,210
+279% +$1.58M 0.01% 1065
2018
Q4 		$539K Buy
36,686
+25,386
+225% +$333K ﹤0.01% 1076
2018
Q3 		$177K Buy
+11,300
New +$162K ﹤0.01% 1027

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Arrowstreet Capital's ZYME Position: Q2 2026 in Review

Arrowstreet Capital reduced its Zymeworks (ZYME) stake by 44% in Q2 2026, selling an estimated $8.27M and leaving 418,497 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Arrowstreet Capital first reported a position in ZYME in Q3 2018 and has held it in 15 quarters since. The position peaked at $18.6M in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Arrowstreet Capital held 418,497 shares of Zymeworks worth $10.9M as of Q2 2026.
  • Arrowstreet Capital sold 325,401 Zymeworks shares in Q2 2026, an estimated $8.27M.
  • Zymeworks made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1047 holding.
  • Arrowstreet Capital first reported a position in Zymeworks in Q3 2018 and has held it in 15 quarters since.
  • Arrowstreet Capital's Zymeworks position peaked at $18.6M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.